课题基金 / 基金详情

Small molecule-regulated gene silencing technologies

Small molecule-regulated gene silencing technologies
小分子调控基因沉默技术
批准号:
0755053
负责人:
Yohei Yokobayashi
金额:
$39.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2012-03-31

项目摘要

项目成果

Yohei Yokobayashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CBET-0755053YokobaysahiIntellectual merit Since its recent discovery, RNA interference (RNAi) has emerged as a powerful tool for biologists to selectively repress expression of virtually any gene of their choice. RNAi has helped researchers to discover novel gene functions and how various genes interact, which are crucial to understanding the molecular basis of many biological processes and diseases. Additionally, numerous academic and industrial groups are intensively developing technologies to use RNAi to treat and cure diseases. Consequently, RNAi is expected to become an important technology for both basic science and applications. The goal of this project is to develop novel technologies to control when and where RNAi is induced by small molecule drugs. Chemically-regulated RNAi enables study of genes that are essential for cell survival or growth, observation of dynamic cellular functions, and increased safety for therapeutic applications. The presently available techniques, however, require coexpression of complex engineered protein(s), which can cause immunogenic complications or toxicity. The Principal Investigator's (PI's) proposed strategies harness the ability of RNA to specifically interact with a variety of compounds to engineer RNA to act as both a chemical sensor and RNAi inducer. The results are genetically small, protein-free, RNA nanomachines which sense specific signal molecules in the cell and decide whether or not to trigger RNAi. Broader impacts Although RNAi has quickly become a routine technique in many academic and industrial laboratories, students, especially undergraduate students, have very little opportunity to learn and practice the important technology. This project will allow a number of Biomedical Engineering students at UC Davis to gain hands-on experience with RNAi through the Senior Design course. The students will, in small groups, design novel chemically regulated RNAi systems, construct plasmid vectors to express them in mammalian cell lines, and study their functions over two academic quarters. Through this project, the students will gain valuable experience with RNAi and various bioengineering techniques in a team-oriented environment. Additionally, the research group will host one or two high school students per summer to engage in laboratory research through UC Davis Young Scholars Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SHF: Small: Evolvability and Robustness of Synthetic Gene Circuits in Bacteria
  • 批准号:
    1016357
  • 项目类别:
    Standard Grant
  • 资助金额:
    $45.0万
  • 财政年份:
    2010
  • 负责人:
    Yohei Yokobayashi
  • 依托单位:
EMT/BSSE: RNA switches and logic gates for biomolecular computation in vitro
  • 批准号:
    0829536
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $44.99万
  • 财政年份:
    2008
  • 负责人:
    Yohei Yokobayashi
  • 依托单位:
CompBio: Dual selection system for evolution of genetic circuits in vivo
  • 批准号:
    0621523
  • 项目类别:
    Standard Grant
  • 资助金额:
    $30.0万
  • 财政年份:
    2006
  • 负责人:
    Yohei Yokobayashi
  • 依托单位:
国内基金
海外基金
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
活细胞单分子成像定量研究EGFR内吞途径命运选择
中性粒细胞在体内条件下重编程为造血干祖细胞的研究
  • 批准号:
    92068101
  • 项目类别:
    重大研究计划
  • 资助金额:
    80.0万元
  • 批准年份:
    2020
  • 负责人:
    程林
  • 依托单位:
小分子化合物促进肝细胞增殖和肝脏再生的研究
  • 批准号:
    32000504
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    郭任
  • 依托单位: